
NATURE . COM {
}
Title:
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice | Nature
Description:
Two papers in this issue report the identification of a specific type of colon cancer cell that initiates tumour growth in mice. This lends support to the theory that only a few cells within a tumour, the cancer stem cells, are responsible for tumour formation and maintenance. The finding highlights the importance of finding therapeutics to target cancer stem cells. Colon cancer is one of the best-understood neoplasms from a genetic perspective1,2,3, yet it remains the second most common cause of cancer-related death, indicating that some of its cancer cells are not eradicated by current therapies4,5. What has yet to be established is whether every colon cancer cell possesses the potential to initiate and sustain tumour growth, or whether the tumour is hierarchically organized so that only a subset of cells—cancer stem cells—possess such potential6,7. Here we use renal capsule transplantation in immunodeficient NOD/SCID mice to identify a human colon cancer-initiating cell (CC-IC). Purification experiments established that all CC-ICs were CD133+; the CD133- cells that comprised the majority of the tumour were unable to initiate tumour growth. We calculated by limiting dilution analysis that there was one CC-IC in 5.7 × 104 unfractionated tumour cells, whereas there was one CC-IC in 262 CD133+ cells, representing >200-fold enrichment. CC-ICs within the CD133+ population were able to maintain themselves as well as differentiate and re-establish tumour heterogeneity upon serial transplantation. The identification of colon cancer stem cells that are distinct from the bulk tumour cells provides strong support for the hierarchical organization of human colon cancer, and their existence suggests that for therapeutic strategies to be effective, they must target the cancer stem cells.
Website Age:
30 years and 10 months (reg. 1994-08-11).
Matching Content Categories {📚}
- Science
- Education
- Health & Fitness
Content Management System {📝}
What CMS is nature.com built with?
Custom-built
No common CMS systems were detected on Nature.com, and no known web development framework was identified.
Traffic Estimate {📈}
What is the average monthly size of nature.com audience?
🌠 Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Nature.com Make Money? {💸}
Display Ads {🎯}
The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.
Ads are managed by yourbow.com. Particular relationships are as follows:
Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.comReseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.comHow Much Does Nature.com Make? {💰}
Display Ads {🎯}
$63,100 per month
Our estimates place Nature.com's monthly online earnings from display ads at $42,042 to $115,616.
Keywords {🔍}
cancer, article, cells, google, scholar, nature, cas, stem, cell, colon, tumour, human, access, dick, research, supplementary, content, cookies, data, information, mice, ads, canada, ontario, privacy, analysis, growth, colorectal, initiating, john, identification, open, molecular, natl, leukemia, clarke, membrane, manuscript, health, jed, institute, author, toronto, permissions, figure, advertising, journal, subscribe, immunodeficient, obrien,
Topics {✒️}
nature portfolio privacy policy colorectal cancer development advertising permissions reprints cells—cancer stem cells—possess canada research chair social media nature immunol nature med health research integrated multi-omics unveils nature 432 nature 414 nature 367 nature nature 445 author information authors p53-independent cross-talk human colon cancer springerlink instant access colon cancer cell immunodeficient nod/scid mice author contributions author correspondence colon cancer cells permissions information colorectal cancer tumorigenesis human colon cancers cancer stem cells competing financial interests personal data /reprints university health network national cancer institute privacy cancer-related death rectal cancer surgery initiating tumour growth permissions cell signaling pathways data protection analysed data natl cancer inst orthotopic xenograft models nod/scid mice explore content subscription content colorectal cancer bulk tumour cells
Schema {🗺️}
WebPage:
mainEntity:
headline:A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
description:Two papers in this issue report the identification of a specific type of colon cancer cell that initiates tumour growth in mice. This lends support to the theory that only a few cells within a tumour, the cancer stem cells, are responsible for tumour formation and maintenance. The finding highlights the importance of finding therapeutics to target cancer stem cells. Colon cancer is one of the best-understood neoplasms from a genetic perspective1,2,3, yet it remains the second most common cause of cancer-related death, indicating that some of its cancer cells are not eradicated by current therapies4,5. What has yet to be established is whether every colon cancer cell possesses the potential to initiate and sustain tumour growth, or whether the tumour is hierarchically organized so that only a subset of cellsâcancer stem cellsâpossess such potential6,7. Here we use renal capsule transplantation in immunodeficient NOD/SCID mice to identify a human colon cancer-initiating cell (CC-IC). Purification experiments established that all CC-ICs were CD133+; the CD133- cells that comprised the majority of the tumour were unable to initiate tumour growth. We calculated by limiting dilution analysis that there was one CC-IC in 5.7âÃâ104 unfractionated tumour cells, whereas there was one CC-IC in 262 CD133+ cells, representing >200-fold enrichment. CC-ICs within the CD133+ population were able to maintain themselves as well as differentiate and re-establish tumour heterogeneity upon serial transplantation. The identification of colon cancer stem cells that are distinct from the bulk tumour cells provides strong support for the hierarchical organization of human colon cancer, and their existence suggests that for therapeutic strategies to be effective, they must target the cancer stem cells.
datePublished:2006-11-19T00:00:00Z
dateModified:2006-11-19T00:00:00Z
pageStart:106
pageEnd:110
sameAs:https://doi.org/10.1038/nature05372
keywords:
Science
Humanities and Social Sciences
multidisciplinary
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnature05372/MediaObjects/41586_2007_Article_BFnature05372_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnature05372/MediaObjects/41586_2007_Article_BFnature05372_Fig2_HTML.jpg
isPartOf:
name:Nature
issn:
1476-4687
0028-0836
volumeNumber:445
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Catherine A. OâBrien
affiliation:
name:University Health Network
address:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
type:PostalAddress
type:Organization
type:Person
name:Aaron Pollett
affiliation:
name:Department of Pathology and Laboratory Medicine
address:
name:Department of Pathology and Laboratory Medicine,
type:PostalAddress
type:Organization
type:Person
name:Steven Gallinger
affiliation:
name:Mount Sinai Hospital
address:
name:Center for Cancer Genetics-Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
type:PostalAddress
type:Organization
type:Person
name:John E. Dick
affiliation:
name:University Health Network
address:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
type:PostalAddress
type:Organization
name:University of Toronto
address:
name:
Department of Molecular and Medical Genetics, University of Toronto, Toronto, Canada
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
description:Two papers in this issue report the identification of a specific type of colon cancer cell that initiates tumour growth in mice. This lends support to the theory that only a few cells within a tumour, the cancer stem cells, are responsible for tumour formation and maintenance. The finding highlights the importance of finding therapeutics to target cancer stem cells. Colon cancer is one of the best-understood neoplasms from a genetic perspective1,2,3, yet it remains the second most common cause of cancer-related death, indicating that some of its cancer cells are not eradicated by current therapies4,5. What has yet to be established is whether every colon cancer cell possesses the potential to initiate and sustain tumour growth, or whether the tumour is hierarchically organized so that only a subset of cellsâcancer stem cellsâpossess such potential6,7. Here we use renal capsule transplantation in immunodeficient NOD/SCID mice to identify a human colon cancer-initiating cell (CC-IC). Purification experiments established that all CC-ICs were CD133+; the CD133- cells that comprised the majority of the tumour were unable to initiate tumour growth. We calculated by limiting dilution analysis that there was one CC-IC in 5.7âÃâ104 unfractionated tumour cells, whereas there was one CC-IC in 262 CD133+ cells, representing >200-fold enrichment. CC-ICs within the CD133+ population were able to maintain themselves as well as differentiate and re-establish tumour heterogeneity upon serial transplantation. The identification of colon cancer stem cells that are distinct from the bulk tumour cells provides strong support for the hierarchical organization of human colon cancer, and their existence suggests that for therapeutic strategies to be effective, they must target the cancer stem cells.
datePublished:2006-11-19T00:00:00Z
dateModified:2006-11-19T00:00:00Z
pageStart:106
pageEnd:110
sameAs:https://doi.org/10.1038/nature05372
keywords:
Science
Humanities and Social Sciences
multidisciplinary
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnature05372/MediaObjects/41586_2007_Article_BFnature05372_Fig1_HTML.jpg
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fnature05372/MediaObjects/41586_2007_Article_BFnature05372_Fig2_HTML.jpg
isPartOf:
name:Nature
issn:
1476-4687
0028-0836
volumeNumber:445
type:
Periodical
PublicationVolume
publisher:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Catherine A. OâBrien
affiliation:
name:University Health Network
address:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
type:PostalAddress
type:Organization
type:Person
name:Aaron Pollett
affiliation:
name:Department of Pathology and Laboratory Medicine
address:
name:Department of Pathology and Laboratory Medicine,
type:PostalAddress
type:Organization
type:Person
name:Steven Gallinger
affiliation:
name:Mount Sinai Hospital
address:
name:Center for Cancer Genetics-Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
type:PostalAddress
type:Organization
type:Person
name:John E. Dick
affiliation:
name:University Health Network
address:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
type:PostalAddress
type:Organization
name:University of Toronto
address:
name:
Department of Molecular and Medical Genetics, University of Toronto, Toronto, Canada
type:PostalAddress
type:Organization
email:[email protected]
type:Person
isAccessibleForFree:
hasPart:
isAccessibleForFree:
cssSelector:.main-content
type:WebPageElement
["Periodical","PublicationVolume"]:
name:Nature
issn:
1476-4687
0028-0836
volumeNumber:445
Organization:
name:Nature Publishing Group UK
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:University Health Network
address:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
type:PostalAddress
name:Department of Pathology and Laboratory Medicine
address:
name:Department of Pathology and Laboratory Medicine,
type:PostalAddress
name:Mount Sinai Hospital
address:
name:Center for Cancer Genetics-Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
type:PostalAddress
name:University Health Network
address:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
type:PostalAddress
name:University of Toronto
address:
name:
Department of Molecular and Medical Genetics, University of Toronto, Toronto, Canada
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Catherine A. OâBrien
affiliation:
name:University Health Network
address:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
type:PostalAddress
type:Organization
name:Aaron Pollett
affiliation:
name:Department of Pathology and Laboratory Medicine
address:
name:Department of Pathology and Laboratory Medicine,
type:PostalAddress
type:Organization
name:Steven Gallinger
affiliation:
name:Mount Sinai Hospital
address:
name:Center for Cancer Genetics-Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
type:PostalAddress
type:Organization
name:John E. Dick
affiliation:
name:University Health Network
address:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
type:PostalAddress
type:Organization
name:University of Toronto
address:
name:
Department of Molecular and Medical Genetics, University of Toronto, Toronto, Canada
type:PostalAddress
type:Organization
email:[email protected]
PostalAddress:
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
name:Department of Pathology and Laboratory Medicine,
name:Center for Cancer Genetics-Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Canada
name:Division of Cell and Molecular Biology, University Health Network, Toronto, Canada
name:
Department of Molecular and Medical Genetics, University of Toronto, Toronto, Canada
WebPageElement:
isAccessibleForFree:
cssSelector:.main-content
External Links {🔗}(81)
- How much does https://link.springer.com/article/10.1038/nature05372?utm_source=nature&utm_medium=referral&utm_campaign=buyArticle earn?
- Check the income stats for https://doi.org/10.1016%2F0092-8674%2890%2990186-I
- Financial intake of http://scholar.google.com/scholar_lookup?&title=A%20genetic%20model%20for%20colorectal%20cancer%20tumorigenesis&journal=Cell&doi=10.1016%2F0092-8674%2890%2990186-I&volume=61&pages=759-767&publication_year=1990&author=Fearon%2CER&author=Vogelstein%2CB
- What's the financial outcome of https://doi.org/10.1096%2Ffasebj.6.10.1321771?
- How much does http://scholar.google.com/scholar_lookup?&title=Progressing%20toward%20a%20molecular%20description%20of%20colorectal%20cancer%20development&journal=FASEB%20J.&doi=10.1096%2Ffasebj.6.10.1321771&volume=6&pages=2783-2790&publication_year=1992&author=Fearon%2CER&author=Jones%2CPA pull in?
- Profit of https://doi.org/10.1126%2Fscience.1104815
- Get to know what's the income of http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2005Sci...307.1904R
- What's the financial gain of http://scholar.google.com/scholar_lookup?&title=Self-renewal%20and%20cancer%20of%20the%20gut%3A%20two%20sides%20of%20a%20coin&journal=Science&doi=10.1126%2Fscience.1104815&volume=307&pages=1904-1909&publication_year=2005&author=Radtke%2CF&author=Clevers%2CH?
- How much profit does https://doi.org/10.1093%2Fjnci%2F93.8.583 generate?
- Earnings of http://scholar.google.com/scholar_lookup?&title=Guidelines%202000%20for%20colon%20and%20rectal%20cancer%20surgery&journal=J.%20Natl%20Cancer%20Inst.&doi=10.1093%2Fjnci%2F93.8.583&volume=93&pages=583-596&publication_year=2001&author=Nelson%2CH
- What is the monthly revenue of https://doi.org/10.1093%2Fjnci%2Fdjh275?
- What's the financial intake of http://scholar.google.com/scholar_lookup?&title=Colon%20cancer%20survival%20rates%20with%20the%20new%20American%20Joint%20Committee%20on%20Cancer%20sixth%20edition%20staging&journal=J.%20Natl%20Cancer%20Inst.&doi=10.1093%2Fjnci%2Fdjh275&volume=96&pages=1420-1425&publication_year=2004&author=O%27Connell%2CJB&author=Maggard%2CMA&author=Ko%2CCY?
- How much does https://doi.org/10.1073%2Fpnas.0830967100 pull in?
- http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2003PNAS..100.3547D's financial summary
- See how much http://scholar.google.com/scholar_lookup?&title=Breast%20cancer%20stem%20cells%20revealed&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.0830967100&volume=100&pages=3547-3549&publication_year=2003&author=Dick%2CJE makes per month
- How much revenue does https://doi.org/10.1016%2Fj.tcb.2005.07.004 bring in?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=Cancer%20stem%20cells%3A%20lessons%20from%20leukemia&journal=Trends%20Cell%20Biol.&doi=10.1016%2Fj.tcb.2005.07.004&volume=15&pages=494-501&publication_year=2005&author=Wang%2CJC&author=Dick%2CJE?
- Discover the revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=8899423
- How much money does http://scholar.google.com/scholar_lookup?&title=Efficiency%20of%20orthotopic%20xenograft%20models%20for%20human%20colon%20cancers&journal=In%20Vivo&volume=10&pages=463-469&publication_year=1996&author=Pocard%2CM&author=Tsukui%2CH&author=Salmon%2CRJ&author=Dutrillaux%2CB&author=Poupon%2CMF generate?
- Get to know https://doi.org/10.1158%2F0008-5472.CAN-04-2488's earnings
- How much does http://scholar.google.com/scholar_lookup?&title=Elimination%20of%20hepatic%20metastases%20of%20colon%20cancer%20cells%20via%20p53-independent%20cross-talk%20between%20irinotecan%20and%20Apo2%20ligand%2FTRAIL&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-04-2488&volume=64&pages=9105-9114&publication_year=2004&author=Ravi%2CR earn?
- What's the financial intake of https://doi.org/10.1158%2F0008-5472.CAN-04-2484?
- How much does http://scholar.google.com/scholar_lookup?&title=SKI-606%2C%20a%20Src%2FAbl%20inhibitor%20with%20in%20vivo%20activity%20in%20colon%20tumor%20xenograft%20models&journal=Cancer%20Res.&doi=10.1158%2F0008-5472.CAN-04-2484&volume=65&pages=5358-5364&publication_year=2005&author=Golas%2CJM make?
- https://doi.org/10.1002%2F%28SICI%291097-0339%28199702%2916%3A2%3C132%3A%3AAID-DC7%3E3.0.CO%3B2-J income
- Find out how much http://scholar.google.com/scholar_lookup?&title=Cytokeratins%2020%20and%207%20in%20the%20differential%20diagnosis%20of%20metastatic%20carcinoma%20in%20cytologic%20specimens&journal=Diagn.%20Cytopathol.&doi=10.1002%2F%28SICI%291097-0339%28199702%2916%3A2%3C132%3A%3AAID-DC7%3E3.0.CO%3B2-J&volume=16&pages=132-136&publication_year=1997&author=Sack%2CMJ&author=Roberts%2CSA earns monthly
- How much does https://doi.org/10.1016%2Fj.canlet.2003.10.032 rake in every month?
- Discover the revenue of http://scholar.google.com/scholar_lookup?&title=Ki-67%20and%20CEA%20expression%20as%20prognostic%20markers%20in%20Dukes%27%20C%20colorectal%20cancer&journal=Cancer%20Lett.&doi=10.1016%2Fj.canlet.2003.10.032&volume=207&pages=109-115&publication_year=2004&author=Ishida%2CH
- What's the financial gain of https://doi.org/10.1002%2Fbjs.4447?
- How profitable is http://scholar.google.com/scholar_lookup?&title=Microvessel%20density%2C%20cyclo-oxygenase%202%20expression%2C%20K-ras%20mutation%20and%20p53%20overexpression%20in%20colonic%20cancer&journal=Br.%20J.%20Surg.&doi=10.1002%2Fbjs.4447&volume=91&pages=355-361&publication_year=2004&author=Liang%2CJT?
- How much does https://doi.org/10.1038%2Fbjc.1963.78 make?
- What's the financial outcome of http://scholar.google.com/scholar_lookup?&title=The%20efficient%20design%20of%20transplantable%20tumour%20assays&journal=Br.%20J.%20Cancer&doi=10.1038%2Fbjc.1963.78&volume=17&pages=583-595&publication_year=1964&author=Porter%2CEH&author=Berry%2CRJ?
- http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=9166828's revenue stream
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=Primitive%20human%20hematopoietic%20cells%20are%20enriched%20in%20cord%20blood%20compared%20with%20adult%20bone%20marrow%20or%20mobilized%20peripheral%20blood%20as%20measured%20by%20the%20quantitative%20in%20vivo%20SCID-repopulating%20cell%20assay&journal=Blood&volume=89&pages=3919-3924&publication_year=1997&author=Wang%2CJC&author=Doedens%2CM&author=Dick%2CJE?
- How much does https://doi.org/10.1073%2Fpnas.0530291100 bring in each month?
- How much does http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2003PNAS..100.3983A bring in each month?
- How much does http://scholar.google.com/scholar_lookup?&title=Prospective%20identification%20of%20tumorigenic%20breast%20cancer%20cells&journal=Proc.%20Natl%20Acad.%20Sci.%20USA&doi=10.1073%2Fpnas.0530291100&volume=100&pages=3983-3988&publication_year=2003&author=Al%20Hajj%2CM&author=Wicha%2CMS&author=Benito-Hernandez%2CA&author=Morrison%2CSJ&author=Clarke%2CMF pull in monthly?
- How much cash flow does https://doi.org/10.1038%2Fnature03128 have monthly?
- How much does http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2004Natur.432..396S pull in?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=Identification%20of%20human%20brain%20tumour%20initiating%20cells&journal=Nature&doi=10.1038%2Fnature03128&volume=432&pages=396-401&publication_year=2004&author=Singh%2CSK?
- Discover the revenue of https://doi.org/10.1038%2F35102167
- Profit of http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=2001Natur.414..105R
- How much does http://scholar.google.com/scholar_lookup?&title=Stem%20cells%2C%20cancer%2C%20and%20cancer%20stem%20cells&journal=Nature&doi=10.1038%2F35102167&volume=414&pages=105-111&publication_year=2001&author=Reya%2CT&author=Morrison%2CSJ&author=Clarke%2CMF&author=Weissman%2CIL pull in monthly?
- https://doi.org/10.1242%2Fjcs.02439's financial summary
- Explore the financials of http://scholar.google.com/scholar_lookup?&title=Release%20of%20extracellular%20membrane%20particles%20carrying%20the%20stem%20cell%20marker%20prominin-1%20%28CD133%29%20from%20neural%20progenitors%20and%20other%20epithelial%20cells&journal=J.%20Cell%20Sci.&doi=10.1242%2Fjcs.02439&volume=118&pages=2849-2858&publication_year=2005&author=Marzesco%2CAM
- What's the financial outcome of https://doi.org/10.1074%2Fjbc.275.8.5512?
- Revenue of http://scholar.google.com/scholar_lookup?&title=The%20human%20AC133%20hematopoietic%20stem%20cell%20antigen%20is%20also%20expressed%20in%20epithelial%20cells%20and%20targeted%20to%20plasma%20membrane%20protrusions&journal=J.%20Biol.%20Chem.&doi=10.1074%2Fjbc.275.8.5512&volume=275&pages=5512-5520&publication_year=2000&author=Corbeil%2CD
- What's the monthly money flow for https://doi.org/10.1016%2Fj.exphem.2005.05.018?
- How much does http://scholar.google.com/scholar_lookup?&title=Dynamic%20changes%20in%20cellular%20and%20microenvironmental%20composition%20can%20be%20controlled%20to%20elicit%20in%20vitro%20human%20hematopoietic%20stem%20cell%20expansion&journal=Exp.%20Hematol.&doi=10.1016%2Fj.exphem.2005.05.018&volume=33&pages=1229-1239&publication_year=2005&author=Madlambayan%2CGJ net monthly?
- What's the total monthly financial gain of https://doi.org/10.1038%2F367645a0?
- How much does http://adsabs.harvard.edu/cgi-bin/nph-data_query?link_type=ABSTRACT&bibcode=1994Natur.367..645L net monthly?
- What are the earnings of http://scholar.google.com/scholar_lookup?&title=A%20cell%20initiating%20human%20acute%20myeloid%20leukemia%20after%20transplantation%20into%20SCID%20mice&journal=Nature&doi=10.1038%2F367645a0&volume=367&pages=645-648&publication_year=1994&author=Lapidot%2CT?
- How much profit does https://doi.org/10.1038%2Fni1080 make?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Acute%20myeloid%20leukemia%20originates%20from%20a%20hierarchy%20of%20leukemic%20stem%20cell%20classes%20that%20differ%20in%20self-renewal%20capacity&journal=Nature%20Immunol.&doi=10.1038%2Fni1080&volume=5&pages=738-743&publication_year=2004&author=Hope%2CKJ&author=Jin%2CL&author=Dick%2CJE?
- Discover the revenue of https://doi.org/10.1038%2Fsj.onc.1207947
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Self-renewal%20and%20solid%20tumor%20stem%20cells&journal=Oncogene&doi=10.1038%2Fsj.onc.1207947&volume=23&pages=7274-7282&publication_year=2004&author=Al%20Hajj%2CM&author=Clarke%2CMF bring in?
- Find out how much https://doi.org/10.1038%2Fnm1379 earns monthly
- Learn how profitable http://scholar.google.com/scholar_lookup?&title=Roots%20and%20stems%3A%20stem%20cells%20in%20cancer&journal=Nature%20Med.&doi=10.1038%2Fnm1379&volume=12&pages=296-300&publication_year=2006&author=Polyak%2CK&author=Hahn%2CWC is on a monthly basis
- What is the earnings of https://doi.org/10.1016%2Fj.gde.2003.11.007?
- How much does http://scholar.google.com/scholar_lookup?&title=Therapeutic%20implications%20of%20cancer%20stem%20cells&journal=Curr.%20Opin.%20Genet.%20Dev.&doi=10.1016%2Fj.gde.2003.11.007&volume=14&pages=43-47&publication_year=2004&author=Al%20Hajj%2CM&author=Becker%2CMW&author=Wicha%2CM&author=Weissman%2CI&author=Clarke%2CMF earn?
- What are the earnings of https://citation-needed.springer.com/v2/references/10.1038/nature05372?format=refman&flavour=references?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Catherine%20A.%20O%E2%80%99Brien's total income per month
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Catherine%20A.%20O%E2%80%99Brien%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en produce monthly?
- What are the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Aaron%20Pollett?
- How much profit does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Aaron%20Pollett%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en make?
- https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Steven%20Gallinger's financial summary
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Steven%20Gallinger%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much revenue does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=John%20E.%20Dick generate?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22John%20E.%20Dick%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- What are the total earnings of https://static-content.springer.com/esm/art%3A10.1038%2Fnature05372/MediaObjects/41586_2007_BFnature05372_MOESM1_ESM.pdf?
- How much money does https://static-content.springer.com/esm/art%3A10.1038%2Fnature05372/MediaObjects/41586_2007_BFnature05372_MOESM2_ESM.doc generate?
- How much money does https://s100.copyright.com/AppDispatchServlet?title=A%20human%20colon%20cancer%20cell%20capable%20of%20initiating%20tumour%20growth%20in%20immunodeficient%20mice&author=Catherine%20A.%20O%E2%80%99Brien%20et%20al&contentID=10.1038%2Fnature05372©right=Springer%20Nature%20Limited&publication=0028-0836&publicationDate=2006-11-19&publisherName=SpringerNature&orderBeanReset=true generate?
- How much does https://citation-needed.springer.com/v2/references/10.1038/nature05372?format=refman&flavour=citation net monthly?
- How much does https://doi.org/10.1186/s11658-024-00554-0 bring in each month?
- What's the income generated by https://doi.org/10.1038/s43018-024-00723-2 each month?
- https://doi.org/10.1038/s41467-024-47227-2 income
- https://doi.org/10.1007/s10555-023-10149-4 income
- How much profit does https://doi.org/10.1186/s13046-023-02931-7 generate?
- How much income does https://www.protocols.io/ have?
- Get to know what's the income of https://www.natureindex.com/
- How much does http://www.naturechina.com generate monthly?
- How much does https://www.natureasia.com/ja-jp gross monthly?
Analytics and Tracking {📊}
- Google Tag Manager
Libraries {📚}
- Prism.js
- Zoom.js
Emails and Hosting {✉️}
Mail Servers:
- mxa-002c5801.gslb.pphosted.com
- mxb-002c5801.gslb.pphosted.com
Name Servers:
- pdns1.ultradns.net
- pdns2.ultradns.net
- pdns3.ultradns.org
- pdns4.ultradns.org
- pdns5.ultradns.info
- pdns6.ultradns.co.uk
CDN Services {📦}
- Crossref